Buy Keytruda Injection100mg/4ml Online

Keytruda Injection 100 mg/4 mL is a humanized monoclonal antibody that targets the programmed death receptor‑1 (PD‑1) pathway. By blocking the interaction between PD‑1 and its ligands (PD‑L1 and PD‑L2), it helps restore immune system activity against abnormal or malignant cells.

This formulation is designed for oncological and immunotherapeutic use under strict medical supervision. It is manufactured to pharmaceutical‑grade standards, ensuring purity, stability, and consistent clinical performance.

Keytruda Injection Specifications

Keytruda Injection Dosage & Administration

Note: Keytruda must be administered by qualified healthcare professionals in a clinical setting.

• Route: Intravenous infusion only — do not administer as a bolus injection.
• Preparation: Dilute in sterile 0.9 % sodium chloride or 5 % dextrose solution before infusion.
• Infusion Time: Typically over 30 minutes using an infusion set with a sterile, low‑protein‑binding filter.
• Frequency: As prescribed by a physician based on indication, body weight, and treatment protocol.

Keytruda Injection Storage Conditions

• Store at 2 °C – 8 °C (36 °F – 46 °F).
• Do not freeze or shake.
• Protect from light; keep vials in original packaging until use.
• Discard any unused portion after single use.

Keytruda Injection Precautions & Warnings

• For human use only under medical supervision.
• Do not administer to patients with known hypersensitivity to pembrolizumab or excipients.
• Monitor for immune‑related adverse reactions (e.g., pneumonitis, colitis, hepatitis, endocrinopathies).
• Suspend treatment if severe toxicity occurs and manage according to clinical guidelines.
• Pregnancy and lactation: use only if potential benefit outweighs risk.

Keytruda Injection Safety & Handling

• Use aseptic technique during preparation and administration.
• Dispose of vials, needles, and infusion materials according to biohazard regulations.
• Avoid mixing with other medicinal products unless compatibility is confirmed.

Shelf Life

• 24 months from date of manufacture when stored under recommended conditions.

Keytruda Injection Clinical Significance

Keytruda Injection represents a major advancement in immune checkpoint inhibition, offering targeted therapy for various malignancies. Its mechanism of action helps the body’s immune system recognize and combat abnormal cells, improving outcomes in approved indications.

Keytruda Injection 100mg/4m is the trade name for the drug Pembrolizumab. It is injected into a vein through an IV. Keytruda is a prescription oncology medicine that is given by a health care professional.

Keytruda 100 mg

is the trade name for the drug Pembrolizumab. It is injected into a vein through an IV. Keytruda is a prescription oncology medicine that is given by a health care professional.

Keytruda Injection 100mg/4ml Uses :

Keytruda Injection (Pembrolizumab) is used for the treatment of :

• unresectable or metastatic melanoma.
  • metastatic non-small cell lung cancer (NSCLC).
  • patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).
  • adult and pediatric patients with refractory classical Hodgkin lymphoma (cHL), or those who have relapsed after three or more prior lines of therapy.
  • primary mediastinal large B-cell lymphoma (PMBCL).
  • certain types of stomach cancer and
  • a certain type of cervical cancer.

Keytruda Injection Pembrolizumab 100mg/ml Work ?

In the body, there is a type of white blood cell that watches out for signs of infection or disease and can also assault cancer cells. These white blood cells are called T cells. On the surface of these T cells are certain proteins known as programmed cell death receptors (PD-1). So that T cells don’t destroy healthy cells, they use these surface proteins, or PD-1, to bind to and communicate with PD-L1 and PD-L2, proteins that permit cells to escape attack from the body’s immune system.

In other words, when the PD-1 protein on T cells comes in contact with PD-L1 and PD-L2 proteins, they are given the signal to allow that cell to live and spread. By blocking PD-1, Pembrolizumab increases the ability of your immune system to attack melanoma cells and tumors. This cancer medicine can release T cells so that it can penetrate melanoma anywhere in your body.

Keytruda Injection Side – Effects :

This medicine may cause some serious, life-threatening side-effects. This does not mean that everyone who takes it will experience them. It depends on the medicine and how your body reacts. The following are some of the side effects that are known to be associated with this medicine :

Common Side Effects : Cough ; Joint pain ; Feeling tired ; Loss of appetite ; Mild diarrhea or constipation ; Difficulty falling asleep or staying asleep ; Changes in skin color etc.

Serious Side Effects : Chest pain or shortness of breath ; New or worsening cough ; Pale skin ; Easy bruising or bleeding ; Severe stomach pain ; Bloody or cloudy urine ; Swelling in the ankles or feet ; Rapid heartbeats ; Increased hunger or thirst ; Hoarseness ; Weight gain or weight loss ; Hair loss etc.

These are not all the possible side effects of Pembrolizumab 100mg Injection. If you notice any other side-effects, contact your doctor or pharmacist for further advice.

Keytruda Injection – Storage Details :

Many factors can damage your medication, including heat, air, light, and moisture. It’s important to keep in mind that where you store your medication can affect its potency and safety. Following storage instructions will be helpful in storing the drug in the best of manner. Keytruda 100 mg Keytruda 100 mg Keytruda 100 mg

• Store Pembrolizumab Injection in between 2°C to 8°C.
  • Store in original carton in refrigerator (35 to 46 degrees F) until time of use
  • Keep this anti-cancer drug in a safe place so that children & pets can not reach it.
  • Keep your medicines separate from your spouse or other family members. This will make it less likely that you take the wrong ones by mistake. Keytruda 100 mg Keytruda 100 mg Keytruda 100 mg
  • Discard Keytruda if it contains particulate matter, is cloudy, or discolored.